Cloning of Human Type I Interferon CDNAs

Overview

Journal Proc Jpn Acad Ser B Phys Biol Sci

Specialties Biology
Science

Date 2023 Aug 30

PMID 37648466

Authors

Shigekazu Nagata

Affiliations

Soon will be listed here.

Abstract

In the late 1970s, crude interferon samples were found to exhibit anti-tumour activity. This discovery led to the interferon as a "magic drug" for cancer patients. Many groups, including those in Tokyo, Zürich, and San Francisco, attempted to identify human interferon cDNAs. Tadatsugu Taniguchi was the first to announce the cloning of human interferon-β cDNA in the December 1979 issue of Proc. Jpn. Acad. Ser. B. This was followed by the cloning of human interferon-α by a Zürich group and interferon-γ by a group in Genentech in San Francisco. Recombinant interferon proteins were produced on a large scale, and interferon-α was widely used to treat C-type hepatitis patients. The biological functions of interferons were quickly elucidated with the purified recombinant interferons. The molecular mechanisms underlying virus-induced interferon gene expression were also examined using cloned chromosomal genes. The background that led to interferon gene cloning and its impact on cytokine gene hunting is described herein.

References

Masucci M, Szigeti R, Klein E, Klein G, Gruest J, Montagnier L . Effect of interferon-alpha 1 from E. coli on some cell functions. Science. 1980; 209(4463):1431-5. DOI: 10.1126/science.6158096. View

Desmyter J, De Groote J, Desmet V, Billiau A, Ray M, Bradburne A . Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet. 1976; 2(7987):645-7. DOI: 10.1016/s0140-6736(76)92460-0. View

ARAI K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T . Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990; 59:783-836. DOI: 10.1146/annurev.bi.59.070190.004031. View

Nagata S, Taira H, Hall A, Johnsrud L, Streuli M, Ecsodi J . Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature. 1980; 284(5754):316-20. DOI: 10.1038/284316a0. View

KNIGHT Jr E, Hunkapiller M, Korant B, Hardy R, HOOD L . Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science. 1980; 207(4430):525-6. DOI: 10.1126/science.7352259. View

Mandel M, Higa A . Calcium-dependent bacteriophage DNA infection. J Mol Biol. 1970; 53(1):159-62. DOI: 10.1016/0022-2836(70)90051-3. View

Taniguchi T, Weissmann C . Inhibition of Qbeta RNA 70S ribosome initiation complex formation by an oligonucleotide complementary to the 3' terminal region of E. coli 16S ribosomal RNA. Nature. 1978; 275(5682):770-2. DOI: 10.1038/275770a0. View

Goeddel D, Leung D, Dull T, Gross M, Lawn R, McCandliss R . The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature. 1981; 290(5801):20-6. DOI: 10.1038/290020a0. View

Efstratiadis A, Kafatos F, Maxam A, Maniatis T . Enzymatic in vitro synthesis of globin genes. Cell. 1976; 7(2):279-88. DOI: 10.1016/0092-8674(76)90027-1. View

10.

Vilcek J, Havell E, Yamazaki S . Antigenic, physicochemical, and biologic characterization of human interferons. Ann N Y Acad Sci. 1977; 284:703-10. DOI: 10.1111/j.1749-6632.1977.tb22006.x. View

11.

Taniguchi T, Mantei N, Schwarzstein M, Nagata S, Muramatsu M, Weissmann C . Human leukocyte and fibroblast interferons are structurally related. Nature. 1980; 285(5766):547-9. DOI: 10.1038/285547a0. View

12.

Schellekens H, de Reus A, Bolhuis R, Fountoulakis M, SCHEIN C, Ecsodi J . Comparative antiviral efficiency of leukocyte and bacterially produced human alpha-interferon in rhesus monkeys. Nature. 1981; 292(5825):775-6. DOI: 10.1038/292775a0. View

13.

Taniguchi T, Ohno S, Fujii-Kuriyama Y, Muramatsu M . The nucleotide sequence of human fibroblast interferon cDNA. Gene. 1980; 10(1):11-5. DOI: 10.1016/0378-1119(80)90138-9. View

14.

Ohno S, Taniguchi T . Structure of a chromosomal gene for human interferon beta. Proc Natl Acad Sci U S A. 1981; 78(9):5305-9. PMC: 348733. DOI: 10.1073/pnas.78.9.5305. View

15.

Piehler J, Thomas C, Garcia K, Schreiber G . Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev. 2012; 250(1):317-34. PMC: 3986811. DOI: 10.1111/imr.12001. View

16.

Taniguchi T, Palmieri M, Weissmann C . QB DNA-containing hybrid plasmids giving rise to QB phage formation in the bacterial host. Nature. 1978; 274(5668):223-8. DOI: 10.1038/274223a0. View

17.

Streuli M, Nagata S, Weissmann C . At least three human type alpha interferons: structure of alpha 2. Science. 1980; 209(4463):1343-7. DOI: 10.1126/science.6158094. View

18.

Zoon K, Smith M, Bridgen P, zur Nedden D, ANFINSEN C . Purification and partial characterization of human lymphoblast interferon. Proc Natl Acad Sci U S A. 1979; 76(11):5601-5. PMC: 411697. DOI: 10.1073/pnas.76.11.5601. View

19.

Parker B, Rautela J, Hertzog P . Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer. 2016; 16(3):131-44. DOI: 10.1038/nrc.2016.14. View

20.

Isaacs A, Lindenmann J, Valentine R . Pillars Article: Virus Interference. II. Some Properties of Interferon. Proc R Soc Lond B Biol Sci. 1957. 147: 268-273. J Immunol. 2015; 195(5):1921-6. View